TP53 and B-cell chronic lymphocytic leukemia: Based on mouse xenograft models, CLL was found to be associated with upregulated USP7 that contributed to aberrant homologous recombination repair, and sensitized p53-deficient, chemotherapy-resistant CLL to clinical doses of chemotherapeutic agents.